By Mark LandlerPublished May 03, 2019 07:53:18If you’ve ever wondered what a bipartisan marijuana bill would look like, or what the chances are that we will get one, it’s time to get excited.
The first bipartisan marijuana legalization bill to come out of Washington state since the end of Prohibition was introduced Monday, by Sens.
Bob Hasegawa (R-Wash.) and Chris Larson (D-Ore.).
This is the second time a bipartisan bill has come out this year and the first since voters approved a constitutional amendment legalizing marijuana for recreational use in Washington state in November.
The legislation is also the first time a legislative chamber has adopted the same model of comprehensive reform proposed by the National Cannabis Industry Association (NCIA), the nation’s largest cannabis trade group.
It’s the latest example of how states have embraced cannabis reform as a way to move forward with a legislative agenda that has stalled under a Democratic administration.
That’s because the opioid epidemic has hit hard in states like California, and cannabis has not been a priority for most Democrats, even though the drug has the potential to be a major contributor to the state’s overall health care system.
The bill is a good example of what can be accomplished when states work together.
Hasegawas bill is part of a larger effort by the state to move beyond the failed failed “War on Drugs,” which failed to curb opioid addiction and created a massive opioid crisis.
The goal is to provide more affordable access to medical marijuana, which Hasegaas bill would allow patients to possess up to six plants.
That would allow for an estimated 40,000 Californians to get access to a medicine that can relieve pain and help them live longer.
The state has been spending millions of dollars on research and medical marijuana research to try to develop a treatment for the opioid crisis, but it’s not clear how effective those efforts have been.
It is also unclear whether California’s new medical marijuana program will be able to adequately treat the opioid problem, particularly in the opioid-addicted population.
The NCIA bill is one of the first steps in what’s expected to be the next major step in the movement toward legalization in California.
The California Cannabis Reform Coalition (CCRC) is working to create a medical cannabis licensing system similar to Colorado, which has had an industry-led program for about a year.
CCRC has proposed a system where dispensaries would register with the state and would be able, in theory, to obtain a license to cultivate medical marijuana.
California already has a system in place for medical marijuana patients who are at least 18 and eligible to grow their own.
However, because the state has not passed a law that allows dispensaries to grow medical marijuana for personal use, there are currently a shortage of qualified patients to get the state medical marijuana cards.
The CCR plan would create a system that allows patients to apply for a license for up to five plants.
The new medical cannabis license would be valid for three years, but the state would have to consider applications from patients with certain illnesses or disabilities.
The bill also would create medical marijuana dispensaries with a cultivation facility and an educational center.
The CCRC is also working on a pilot program in a portion of San Francisco.
In the pilot program, the state will allow medical marijuana businesses to cultivate six to nine plants and sell them for recreational purposes, and the state is also allowing the businesses to provide education to medical cannabis patients.
The new licensing system would allow the state the flexibility to continue to work with private businesses and would provide a model that would be copied by other states.
This approach would allow states to take a hands-off approach toward recreational marijuana production while still allowing patients to obtain medical marijuana if they meet the criteria of a qualifying condition.
The CCRC’s plan would also allow the medical marijuana industry to sell recreational marijuana through a state-run marketplace similar to those in Oregon and Washington state.
California already has some private marketplaces, such as the one in San Francisco, and some retail stores.
The state would allow dispensaries to sell only cannabis products to patients who have been diagnosed with certain conditions, including cancer, AIDS and epilepsy.
The CCR bill is the latest step in a long process.
In 2019, voters approved the first legal recreational marijuana use in the United States.
The Senate passed the bill last year and then the Assembly voted to pass the bill.
In January 2020, the Senate voted to allow recreational marijuana sales.
But the House failed to take up the bill and then died in January.
It was expected to pass in February, but when the bill was sent to the governor for his signature it was rejected by the governor’s office.
The governor is now considering a different bill that would legalize recreational marijuana, and if he signs that bill, it would take effect in February 2019.
The Senate bill is now before the Assembly.
The Assembly is expected to vote on it sometime in the spring, and that vote could happen as early as May.
If it passes,